Speaker(s):
Jason L. Vassy, MD, MPH, MS- Director, Genomes2Veterans Research Program, VA Boston Healthcare System, Associate Professor of Medicine, Harvard Medical School, has nothing to disclose.
Morgan Danowski, MS, CGC- Genetic Counselor and Project Manager, Genomes2Veterans Research Program, VA Boston Healthcare System, discloses the following: Arboretum LifeSciences-Consultant/Advisor.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
- Describe the design and scope of the ProGRESS and MVP-ROAR studies
- Discuss the impact of genomic screening on veteran health outcomes and risk assessment
- Assess current barriers and facilitators for broad implementation of genomic screening in the VA
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Juliann Savatt, MS, LCGC, Melissa Kelly, MS, LCGC, Marc Williams, MD, and Cara McCormick, MPH have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose: Christen Mowad, MD, Alison Mowery, DNP, CRNP
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session:
None
Session date:
07/13/2026 - 12:00pm to 1:00pm EDT
Location:
Virtual via Microsoft Teams
Danville, PA
17822
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation Credit

Facebook
X
LinkedIn
Forward